Q4 2020 Holdings
Filed 2021-02-16 | 67 holdings | $75.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $57.0M | 2,195,892 | 75.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $9.8M | 1,509,812 | 13.0% |
| C4 Therapeutics Inc(CCCC) | COM | 12529R107 | $6.6M | 200,000 | 8.8% |
| Xencor Inc(XNCR) | COM | 98401F105 | $198.4K | 4,547,072 | 0.3% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $133.0K | 3,200,649 | 0.2% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $128.8K | 2,456,854 | 0.2% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $117.4K | 2,533,635 | 0.2% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $113.2K | 9,426,640 | 0.2% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $104.7K | 3,092,218 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $102.0K | 464,298 | 0.1% |
| Morphic Hldg Inc | COM | 61775R105 | $95.3K | 2,839,884 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $69.3K | 3,223,324 | 0.1% |
| Biogen Inc(BIIB)Call | COM | 09062X103 | $62.2K | 254,100 | 0.1% |
| Solid Biosciences Inc | COM | 83422E105 | $60.5K | 7,977,702 | 0.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $57.9K | 1,773,037 | 0.1% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $53.7K | 2,103,950 | 0.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $50.8K | 1,544,019 | 0.1% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $44.0K | 3,122,704 | 0.1% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $39.2K | 2,426,685 | 0.1% |
| Akouos Inc | COM | 00973J101 | $39.2K | 1,975,984 | 0.1% |
| Applied Molecular Trans Inc | COM | 03824M109 | $35.4K | 1,150,000 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $30.1K | 18,939,925 | 0.0% |
| Gossamer BIO Inc | NOTE | 38341PAA0 | $27.2K | $30,000,000 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $19.8K | 1,250,001 | 0.0% |
| Allovir Inc | COM | 019818103 | $17.2K | 447,012 | 0.0% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $13.5K | 3,421,287 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $12.5K | 2,410,240 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $11.6K | 387,357 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $10.9K | 1,000,000 | 0.0% |
| Vincera Pharma Inc | COM | 92731L106 | $10.0K | 480,505 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $9.3K | 741,290 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $9.2K | 800,000 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $8.8K | 260,000 | 0.0% |
| Deerfield Healthcare Tech AC | COM | 244413100 | $7.5K | 481,600 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $6.6K | 400,000 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $6.2K | 100,000 | 0.0% |
| Logicbio Therapeutics Inc | COM | 54142F102 | $5.9K | 775,000 | 0.0% |
| Jiya Acquisition Corp | COM | 47760M102 | $5.2K | 500,000 | 0.0% |
| Health Sciences ACQ Corp 2 ORD | SHS | G4411D109 | $5.1K | 400,000 | 0.0% |
| Panacea Acquisition Corp | UNIT 99/99/9999 | 698102209 | $5.0K | 390,000 | 0.0% |
| Cyclerion Therapeutics Inc(CYCNUSD) | COM | 23255M105 | $4.9K | 1,606,276 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $4.6K | 46,666 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $4.5K | 215,000 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $4.3K | 143,567 | 0.0% |
| Codiak Biosciences Inc(32W) | COM | 192010106 | $3.7K | 115,195 | 0.0% |
| Vincera Pharma Inc | *W EXP | 92731L114 | $3.1K | 150,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $3.1K | 50,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $2.8K | 294,221 | 0.0% |
| Metacrine Inc | COM | 59101E103 | $2.6K | 333,332 | 0.0% |
| Helix Acquisition Corp | COM | G4444C102 | $2.3K | 200,000 | 0.0% |